Medicare Enrolled

Dr. Luis Camacho, M.D., MPH

Hematology & Oncology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
6560 FANNIN STREET, Houston, TX 77030
7137961200
In practice since 2006 (19 years)
NPI: 1336249960 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Camacho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Camacho? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Camacho

Dr. Luis Camacho is a hematology & oncology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Camacho performed 11,739 Medicare services across 504 unique beneficiaries.

Between the years covered by Open Payments, Dr. Camacho received a total of $357,785 from 62 pharmaceutical and/or device companies across 871 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Camacho is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 36% volume in TX $357,785 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,739
Medicare services
Top 36% in TX for hematology & oncology
504
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~618 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 9,900 $0 $2
Dexamethasone injection (steroid) 622 $0 $2
Office visit, established patient, complex (40-54 min) 227 $132 $350
Office visit, established patient (30-39 min) 195 $90 $300
Injection of additional new drug or substance into vein 156 $12 $50
Infusion, normal saline solution, 250 cc 141 $0 $26
Hospital follow-up visit, high complexity 128 $96 $560
Injection, diphenhydramine hcl, up to 50 mg 67 $1 $5
Injection of drug or substance into vein 53 $30 $150
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 40 $50 $239
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 39 $17 $80
Initial hospital admission, high complexity 38 $140 $750
Injection, methylprednisolone sodium succinate, up to 40 mg 30 $3 $20
New patient office visit (45-59 min) 26 $127 $315
New patient office visit, complex (60-74 min) 24 $178 $700
Initial hospital admission, moderate complexity 21 $105 $650
Office visit, established patient (20-29 min) 17 $69 $210
Biopsy and aspiration of bone marrow sample for diagnosis 15 $132 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.9% high complexity
92.4% medium
5.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$357,785
Total received (2018-2024)
Avg $51,112/year across 7 years
Top 2% in TX for hematology & oncology
62
Companies
871
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$339,006 (94.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,542 (2.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,237 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$30,121
2023
$30,992
2022
$42,307
2021
$11,591
2020
$33,258
2019
$107,763
2018
$101,752

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme Corporation
$170,288
Merck Sharp & Dohme LLC
$92,761
Amgen Inc.
$75,856
Exelixis Inc.
$8,274
PFIZER INC.
$2,759
AstraZeneca Pharmaceuticals LP
$965
Lilly USA, LLC
$638
Celgene Corporation
$598
E.R. Squibb & Sons, L.L.C.
$473
Medtronic, Inc.
$447
Medtronic Vascular, Inc.
$349
Genentech USA, Inc.
$339
Bayer HealthCare Pharmaceuticals Inc.
$256
Astellas Pharma US Inc
$228
Incyte Corporation
$223
Eisai Inc.
$222
BeiGene USA, Inc.
$221
Janssen Biotech, Inc.
$218
Teva Pharmaceuticals USA, Inc.
$182
Seagen Inc.
$170
Daiichi Sankyo Inc.
$165
GENZYME CORPORATION
$157
Pharmacyclics LLC, An AbbVie Company
$151
Rigel Pharmaceuticals, Inc.
$127
Janssen Pharmaceuticals, Inc
$108
SECURA BIO, INC.
$90
ABBVIE INC.
$83
PharmaEssentia USA Corporation
$78
EMD Serono, Inc.
$78
Aveo Pharmaceuticals, Inc.
$75
AMAG Pharmaceuticals, Inc.
$73
AVEO Pharmaceuticals, Inc.
$73
Taiho Oncology, Inc.
$61
EISAI INC.
$60
Alexion Pharmaceuticals, Inc.
$57
MorphoSys, US Inc.
$55
Novartis Pharmaceuticals Corporation
$51
Mylan Institutional Inc.
$49
Ipsen Biopharmaceuticals, Inc
$48
Lexicon Pharmaceuticals, Inc.
$48
Kyowa Kirin, Inc.
$46
Karyopharm Therapeutics Inc.
$45
GlaxoSmithKline, LLC.
$45
TerSera Therapeutics LLC
$44
Verastem, Inc.
$44
Mirati Therapeutics, Inc.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Bayer Healthcare Pharmaceuticals Inc.
$37
Puma Biotechnology, Inc.
$36
Secura Bio, Inc.
$28
AbbVie Inc.
$26
ARRAY BIOPHARMA INC
$24
Regeneron Pharmaceuticals, Inc.
$24
Gilead Sciences, Inc.
$22
Dova Pharmaceuticals
$21
Pharming Healthcare, Inc.
$20
Spectrum Pharmaceuticals Inc.
$18
Sun Pharmaceutical Industries Inc.
$16
Seattle Genetics, Inc.
$15
Agios Pharmaceuticals, Inc.
$14
Acrotech Biopharma LLC
$12
INSYS Therapeutics Inc
$12
Top 3 companies account for 94.7% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALIMTA · Abraxane · Alecensa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COPIKTRA · COREVALVE EVOLUT R · CYRAMZA · Cabometyx · Copiktra · CoreValve Evolut · DARZALEX · DAURISMO · Doptelet · ELIQUIS · EMEND · ENHERTU · ERBITUX · ERLEADA · Enhertu · FARYDAK · FERAHEME · FOTIVDA · Folotyn · Fulphila · GILOTRIF · IBRANCE · IMFINZI · IN.PACT Admiral · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KRAZATI · Kyprolis · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · PADCEV · POTELIGEO · Padcev · Pomalyst · Prolia · REBLOZYL · RETEVMO · RUCONEST · Revlimid · Rezlidhia · SARCLISA · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TECENTRIQ · TEFLARO · TIBSOVO · TUKYSA · Tavalisse · Truxima · ULTOMIRIS · VENCLEXTA · VERZENIO · VenaSeal · WELIREG · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for hematology & oncology in TX.

Equivalent to $3,048 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Houston?
Compare hematology & oncology specialists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
202
Per 100K population
4.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Camacho is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Camacho experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Camacho performed 9,900 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Camacho receive payments from pharmaceutical companies?
Yes. Dr. Camacho received a total of $357,785 from 62 companies across 871 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Camacho's costs compare to other hematology & oncology specialists in Houston?
Dr. Camacho's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Camacho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →